Which statement below is TRUE? Becaplermin gel is a commercially available growth factor approved for use only with nonhealing diabetic foot ulcers. Cellular skin substitutes contain non-living products derived from allogeneic, biosynthetic, or synthetic materials. Split-thickness skin grafts are appropriate for deep wounds that are healthy and well-vascularized. HBOT is covered 100
1) Becaplermin gel is a commercially available growth factor approved for use only with nonhealing diabetic foot ulcers.
2) Cellular skin substitutes contain non-living products derived from allogeneic, biosynthetic, or synthetic materials.
3) Split-thickness skin grafts are appropriate for deep wounds that are healthy and well-vascularized.
4) HBOT is covered 100%
